Surgical Placement of Implant Body — Endosteal Implant Template

Surgical placement of implant body - endosteal implant.

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Site: #Tooth number(s)
Implant system: Implant system
Implant lot/serial: Lot/serial/manufacturer
Implant size: Implant size

Implant placement support: Extraction date, reason for tooth loss, PDI/edentulism class
Surgical guide/drill details: Guide/index used, key and drill sizes
Graft/biologic/membrane: Materials used or none
Pre/post-op image support: Diagnostic-quality radiographs/CBCT/photos and findings
Definitive restoration plan: Planned restoration and healing timeline
Indication: Indication/diagnosis
Radiographs/CBCT/photos: Pre-op/post-op images and findings

Consent: Consent/PARQ reviewed; signed/verbally obtained

Anesthesia: Anesthetic used
Carps: Carpules/amount

Procedure:
Incision made.
Mucoperiosteal flap elevated.
Osteotomy prepared with sequential drills.
Implant placed at proper depth and angulation.
Primary stability achieved.
Torque value: Torque value
Cover screw/healing abutment placed.
Flap repositioned.
Sutured with: Suture material/size
Hemostasis achieved.

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Avoid chewing on surgical site.
Rx: Prescription or none

Healing period before restoration: Healing period before restoration

NV: Next visit

Documentation requirements

D6010 is one of the highest-fee surgical codes in general dentistry, and it is also one of the most frequently audited and pre-authorized procedures across both medical and dental carriers. The chart needs to prove (1) the patient was a documented candidate (medical clearance, adequate bone, appropriate site), (2) informed consent covered the surgical and prosthetic plan including alternatives, (3) the implant was placed under guideline-concordant conditions (CBCT-confirmed bone, primary stability, recorded torque, brand / lot / size traceability), and (4) the post-op plan and definitive restorative plan are explicit. Each of these elements has a specific audit and infection-control rationale.

A defensible record includes:

• Medical history reviewed and updated today — meds, conditions, allergies, ASA status, recent hospitalizations. The implant population skews older with comorbidities; the highest-yield items to call out are: anticoagulants / antiplatelets (warfarin, apixaban, rivaroxaban, dabigatran, clopidogrel — INR if on warfarin), antiresorptive / antiangiogenic medications (oral and IV bisphosphonates, denosumab, romosozumab — duration of therapy and MRONJ risk stratification), uncontrolled diabetes (recent A1C; placement is generally deferred above ~A1C 8.0 per AAOMS / AAID risk-management guidance), active smoking (quantified pack-years; smoking cessation counseling documented; smoking is the strongest modifiable risk factor for early implant failure), immunosuppression / chemotherapy / head and neck radiation history (prior radiation dose and field; HBO consideration), active periodontal disease (must be controlled before implant placement), and psychiatric / neurologic conditions that affect post-op compliance.
• Vitals (BP and pulse) at minimum — required by most state boards and all sedation-capable practices on a surgical visit. Hypertensive urgency is a placement-deferring finding; document the recheck and the threshold used.
• Pre-op CBCT confirmation — explicit reference to the CBCT (or pano + PA at minimum, with rationale if CBCT not obtained) read pre-op for bone volume (buccolingual width, apico-coronal height, mesiodistal length between adjacent root structures), bone quality / density (Lekholm & Zarb Type I-IV or Misch D1-D4), proximity to vital structures (inferior alveolar nerve canal, mental foramen, maxillary sinus floor, incisive canal, lingual concavities), and pathology (residual root tips, cysts, retained primary teeth). Per AAOMS and AAID position papers, CBCT is the imaging standard for implant treatment planning at most sites and is the audit-defensible record on dispute.
• Site documentation — tooth number(s) being replaced. This is the line-level identifier that drives the claim.
• Tooth-loss history — reason for tooth loss (caries, periodontal disease, trauma, congenital, endodontic failure), extraction date, prior bone-graft history at the site, and any prior failed implant at the site (with the failure date and reason if known). The "missing-tooth narrative" is one of the most common pre-authorization elements requested by carriers.
• PDI / edentulism class — ACP Prosthodontic Diagnostic Index for partial or complete edentulism. Anchors clinical complexity in the chart and supports any narrative for fee adjustment or pre-auth.
• Implant brand / system / size / lot or serial — the trifecta of traceability. Brand and system (e.g., Straumann BLT, Nobel Active, BioHorizons Tapered Internal, Megagen AnyRidge, Zimmer Biomet T3), diameter (e.g., 4.1 mm), length (e.g., 10 mm), and the lot or serial number from the package label affixed to the chart or scanned into the EHR. Lot traceability is a manufacturer requirement, an FDA UDI requirement on Class II/III medical devices, and a standard audit element on any implant chart.
• Surgical guide / index — note whether a guide was used (static surgical guide, stack guide, dynamic navigation), the key sleeve diameter, the planned vs. achieved depth, and any deviation. Free-hand placement is documented as such with the rationale.
• Drill sequence — the sequence of osteotomy drills used (pilot 2.0 → 2.8 → 3.5 → 4.0 etc.) and the manufacturer's prescribed sequence for the chosen implant system. Many carriers and most expert-witness reviewers expect the sequence to follow the manufacturer's IFU.
• Torque value at final seating — recorded in Ncm (e.g., 35 Ncm). Torque is the proxy for primary stability. Many practices also record an ISQ value if a resonance frequency analysis (RFA / Osstell) device is used. Documenting torque is a standard implant-record element across AAOMS / AAID / ACP guidance and supports the immediate-loading vs. delayed-loading decision.
• Healing protocol selected — explicitly state 1-stage (non-submerged, healing abutment placed today) or 2-stage (submerged, cover screw placed today, second-stage exposure D6011 at ~3-6 months). Drives subsequent visit coding.
• Graft / biologic / membrane — when bone graft is placed concurrently (D6104), document the material (autograft, allograft brand, xenograft brand, alloplast brand), volume in cc, lot number, membrane type if used (resorbable collagen, PTFE, titanium-reinforced), and fixation (tacks, sutures). When no graft is placed, write "none placed" — silence reads as missing documentation, not as absence.
• Anesthesia — agent and concentration (e.g., 4% articaine 1:100,000 epi), number of carpules, technique (infiltration, IAN block, PSA / MSA / ASA, mental block), and any sedation co-administered (D9230 nitrous, D9243 IV sedation moderate, etc.) coded separately.
• Informed consent (PARQ) — Procedure, Alternatives, Risks, and Questions. Risks specific to D6010 must include: failure to osseointegrate, nerve injury (paresthesia / dysesthesia of the lip, chin, or tongue — quantified risk per AAOMS for posterior mandible cases), maxillary sinus communication / sinusitis (for posterior maxilla), infection / peri-implantitis, bone or fixture fracture, need for additional procedures (graft, membrane, second-stage exposure), MRONJ risk in antiresorptive users, prosthetic outcome limitations, and the option to decline implant therapy in favor of fixed bridge, removable partial / complete denture, or no treatment. Signed written consent is best practice; a verbal-consent note must record date, witness, and the specific risks discussed.
• Procedure narrative — incision design (mid-crestal, papilla-sparing, crestal with vertical releasing), flap elevation (full-thickness mucoperiosteal vs. flapless), osteotomy preparation by sequential drill, irrigation (sterile saline, copious external; internal if drill design supports it), implant placement to platform-level depth and confirmed angulation, primary stability achieved, cover screw or healing abutment torqued to manufacturer specification, flap repositioning, suture material and size (e.g., 4-0 chromic gut, 4-0 PTFE), and verified hemostasis.
• Pre-op and post-op imaging — pre-op PA / pano / CBCT findings recorded above; post-op PA confirming implant position, depth, angulation, and absence of damage to adjacent teeth or structures. Document diagnostic quality.
• Definitive restoration plan — planned restoration (single-unit cement-retained crown, screw-retained crown, splinted units, bridge abutment, overdenture attachment), planned abutment type (D6056 prefab vs. D6057 custom), and planned healing period before restoration (typically 2-4 months mandible, 3-6 months maxilla; longer if grafting performed concurrently). Required language for many medical carriers reviewing implants under medical benefits.
• Complications — explicitly noted, even if "none." Common items: lack of primary stability (note any decision to bury and bone-graft vs. abort), perforation of buccal / lingual plate, sinus floor perforation (Schneiderian membrane status), bleeding requiring extra hemostatic measures, fixture-driver disengagement, bone fracture, unexpected resistance.
• Post-op instructions and prescriptions — written instructions reviewed (no chewing on site, soft diet 7-10 days, ice 10-on/10-off x 24-48 hrs, no smoking, chlorhexidine 0.12% rinse 2x/day starting 24 hrs post-op, head elevation while sleeping, no straws). Antibiotic prescription if indicated (amoxicillin 500 mg TID x 7 days is the most common protocol; alternatives for PCN allergy: clindamycin 300 mg QID x 7, azithromycin loading dose then 250 mg daily x 4). Analgesic guidance (NSAID-first per current pain management guidance; opioid only when NSAID contraindicated). Document allergies cross-checked.
• Patient tolerance and response — vital sign re-check on dismissal, post-op confirmation that patient is alert, oriented, and ambulatory; ride-home arrangement if sedation used.
• Provider signature and any auxiliary operator initials — surgeon of record signed, and any restorative dentist / co-treating clinician identified for downstream coordination.

The "amnesia test" applies hard on D6010: a third party reading the chart — and any auditor — must be able to reconstruct why the implant was indicated, what brand / size / lot was placed, how primary stability was confirmed, what consent was obtained, and what the prosthetic plan and timeline are. Generic "implant placed, sutured, post-op given" without the brand / lot / torque / CBCT / consent specifics is the single biggest audit risk on this code.

Common denial reasons

The most common reasons D6010 is denied, downgraded, or recouped:

• No pre-authorization on file — by far the most common denial. D6010 is a pre-auth-default code on most dental and medical carriers. Submitting the surgical claim without an approved pre-auth on file is a procedural denial regardless of clinical appropriateness.
• Missing-tooth clause denial — the carrier finds the tooth being replaced was already missing when the patient's current plan started, and the policy excludes pre-existing missing teeth. Remedy: document extraction date and reason and submit a narrative; sometimes the prior plan's records can defeat the exclusion.
• No implant benefit on the plan — the plan flatly excludes implants or pays only an alternate benefit equivalent to a fixed bridge. The patient and the front desk should know this before the surgery is scheduled, not at claim time.
• Insufficient documentation of brand / size / lot / torque — carrier audit questions whether a billable implant was actually placed. The brand, diameter, length, and lot or serial number are the manufacturer-traceability standard and the chart's anchor against allegations of upcoding or fraud.
• No CBCT or radiographic support submitted — carrier requires diagnostic imaging confirming bone volume and the absence of contraindications. A pre-op CBCT (or pano + PA at minimum) attached to the pre-auth and the claim is the standard.
• Inadequate informed-consent documentation — chart silent on alternatives discussed (no implant therapy, fixed bridge, removable prosthesis), risks specific to the case (nerve injury for posterior mandible, sinus communication for posterior maxilla, MRONJ for antiresorptive users), and the patient's choice. Generic "consent obtained" is increasingly cited as inadequate on audit.
• Same-site prior D6010 in claim history without paired D6100 — frequency violation. The carrier's history shows a prior implant at the same site without a documented removal, so the new D6010 is denied as duplicative.
• Active periodontitis or uncontrolled medical condition documented on the same date — auditors flag implant placement performed in the presence of documented active perio or uncontrolled diabetes (recent A1C above plan or guideline thresholds) as deviating from accepted practice.
• Bone-graft code billed on the same date but rejected as bundled — D6104 or D7953 billed concurrently and denied as inclusive of D6010 by the specific plan; some carriers bundle ridge-preservation or simultaneous grafting under the implant fee. Verify at pre-auth.
• Tooth number missing or incorrect on the claim line — D6010 must be reported with the specific tooth number or quadrant. Missing or mismatched site identifier triggers automatic claim rejection.
• Mismatch between D6010 and a prior bridge / partial that was paid for — the carrier's history shows the same span was previously restored with a bridge or partial covered by the plan; the implant claim is denied for redundancy without a narrative establishing the prior prosthesis failure.
• Second-stage exposure (D6011) billed instead of D6010 at initial placement — coding-sequence error; the codes describe different stages.
• Default-normal templating across multiple implant cases — every implant chart in the practice reads identically with the same brand, the same torque, the same "primary stability achieved." Auditors flag pattern-matched templates as evidence of fabricated documentation. Vary the chart with the actual case.
• Failure to document replacement implant rationale — when D6010 is billed for a replacement after a failed implant (paired with D6100), the chart and claim must explain the failure mode. "Implant failed and replaced" is insufficient; document mobility / peri-implantitis / fracture / loss-of-osseointegration with imaging support.
• Smoker without documented cessation counseling — some plans assess increased liability or deny coverage outright on tobacco-using patients for implant surgery; the chart should show smoking-cessation counseling delivered and documented.

Related templates